Active Ingredient(s):Meropenem + Vaborbactam FDA Approved: * August 29, 2017 Pharm Company: *REMPEX PHARMS MEDCNS Category:Antibiotics
Vaborbactam (INN) is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the β-lactamase enzymes that would otherwise degrade them. When combined with an appropriate antibiotic it can be used for the treatment of gram-negative bacterial infections.
In the United States, the c...
* May have multiple approval dates, manufacturers, or labelers.
Vabomere Intravenous Injection, Powder, for Solution